NasdaqGS - Nasdaq Real Time Price
USD
Gossamer Bio, Inc. (GOSS)
10.38
-0.31
(-2.90%)
At close: October 30 at 4:00:01 PM EDT
10.30
-0.08
(-0.78%)
After hours: October 30 at 6:20:59 PM EDT
Loading chart for GOSS
What's happening with GOSS?
Powered by Yahoo ScoutGossamer Bio’s investment case remains concentrated on seralutinib, its experimental treatment for pulmonary arterial hypertension. The company submitted a New Drug Application to the U.S. Food and Drug Administration in September, while analysts remain divided over the drug’s Phase 3 data, approval odds, and funding needs.
Powered by Yahoo Scout
- Previous Close
10.69 - Open
10.56 - Bid 9.14 x 100
- Ask 8.70 x 100
- Day's Range
10.19 - 10.74 - 52 Week Range
8.29 - 309.60 - Volume
179,363 - Avg. Volume
260,184 - Market Cap (intraday)
63.488M - Beta (5Y Monthly) 2.21
- PE Ratio (TTM)
-- - EPS (TTM)
-52.80 - Earnings Date (est.) Nov 4, 2026
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
95.40 - Zacks Rating Neutral
Recent News
View More
Performance Overview
Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
GOSS
95.81%
S&P 500 (^GSPC)
10.73%
1-Year Return
GOSS
94.64%
S&P 500 (^GSPC)
11.11%
3-Year Return
GOSS
73.95%
S&P 500 (^GSPC)
81.91%
5-Year Return
GOSS
98.96%
S&P 500 (^GSPC)
64.59%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 10/29/2026
-
Market Cap
65.38M
-
Enterprise Value
48.43M
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (current)
--
-
Price/Sales (ttm)
0.65
-
Price/Book (mrq)
--
-
Enterprise Value/Revenue
0.91
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
-235.00%
-
Return on Assets (ttm)
-62.39%
-
Return on Equity (ttm)
--
-
Revenue (ttm)
53.29M
-
Net Income Avi to Common (ttm)
-125.22M
-
Diluted EPS (ttm)
-52.80
Balance Sheet and Cash Flow
-
Total Cash (mrq)
57.03M
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
-29.76M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Mkt Cap
undefined
-
Industry
-
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
